The aim of this study was to compare the antiviral activities in vitro of citral, limonene and essential oils (EOs) from Lippia citriodora and L. alba on the replication of yellow fever virus (YFV). Citral and EOs were active before and after virus adsorption on cells; IC 50 values were between 4.3 and 25 µg/mL and SI ranged from 1.1 to 10.8. Results indicate that citral could contribute to the antiviral activity of the L. citriodora EO. Limonene was not active and seemed to play an insignificant role in the antiviral activity of the examined EOs.
Yellow Fever Virus (YFV) belongs to the Flavivirus genus and possesses an icosahedral nucleocapsid core surrounded by a lipid envelope in which the E and M proteins are embedded. The E protein mediates binding to host cell receptors involved in the virus adsorption and penetration into the cellular cytoplasm [1] . YFV is responsible for devastating epidemics of Yellow-Fever (YF), a hepatic, hemorrhagic and potentially fatal disease with a casefatality rate of 77.3% in 2010 [2] .
An antiviral is not currently available for treatment of YF. Natural products continue to be an important source for the discovery of drugs [3] [4] [5] [6] . Numerous reports describe antiviral activities of plant essential oils (EOs) on enveloped viruses [7] [8] [9] [10] [11] [12] [13] [14] . We have demonstrated inhibitory effects in vitro of EOs from Lippia species on YFV [15 -17] . Antiviral properties of EOs have been attributed to their chemical constituents: sesquiterpenes and monoterpenes are active on enveloped viruses [18, 19] . To our knowledge, there is no documented information about the inhibitory effect of EO-derived constituents on YFV. In the present study the mode of antiviral action of citral, limonene and EOs from L. alba and L. citriodora were compared.
Selected compounds were tested for their cytoxicity to Vero and HeLa cells by using the MTT assay. Results shown in Table 1 indicate that L. citriodora EO and citral were considerably more toxic than L. alba EO and limonene to both cells: CC 50 : 31 -51 versus 165 -920 µg/mL. There was no significant difference between citral and L. citriodora on HeLa cells, although citral was less toxic to Vero cells. Limonene was less toxic than L. alba EO to both cell types. The maximum non-toxic concentration (MNTC) to Vero cells for citral, limonene, L. citriodora and L.alba EOs was 12.5 ± 1.8, 600 ± 3.9, 25 ± 1.1 and 75 ± 3.9 µg/mL, respectively.
In order to investigate the mode of the antiviral action, each compound was added before and after virus adsorption onto the cells. Pre-treatment of YFV with citral at 80 µg/mL for 2 h at 37°C inhibited virus plaques by 72.8%, while treatment after adsorption of untreated-YFV at the same concentration reduced viral progeny by 97.5% (Figure, A) . In contrast, no significant antiviral action was observed by treatment with limonene before and after adsorption of YFV, even when concentrations higher than 100 µg/mL were used. At 400 µg/mL, limonene reduced virus plaques with respect to control only by 31% and 21% (Figure, B) . Treatments with the EO from L. citriodora and L. alba at concentrations between 75 and 80 µg/mL reduced virus plaque by 100%. Figure C shows the inhibitory effect of L. citriodora after YFV adsorption depending on concentration. No inhibition was observed when Vero cells were pre-treated with the test compound for 24 h at 37°C before adsorption of the untreated-virus. A significant reduction of viral progeny with respect to control was not observed (Figure, D).
Relevant antiviral activities of the examined compounds in before and after assays was defined in accordance with the 50% inhibitory concentration (IC 50 ) and selectivity index (SI = CC 50 / IC 50 ) ( Table  2 ). Citral presented IC 50 values between 17.6 and 25.0 μg/mL and an SI of 1.5 and 1.1, similar to those of L. citriodora EO (19.4 and 21.2 μg/mL; 2.6 and 2.4). L. alba EO was the most active, with IC 50 values of 4.3 and 15.2 μg/mL, and SIs of 30.6 and 10.8. The IC 50 for limonene could not be determined because a dose-response curve was not generated from the data although concentrations from 50 to 800 µg/mL were used.
In accordance with the CC 50 values and the classification system of Halle and Göres [20] , L. citriodora EO, citral, L. alba EO, and limonene would be rated as moderately toxic, slightly toxic, non-toxic and non-toxic, respectively. Hayes and Markovic [21] reported citral as very toxic to human hepatocarcinoma cells (Hep-2) and human skin epithelial cells (F1-73), although it was 100-fold and 10-fold greater than in rats and mice, respectively. Thus, in vitro assays might overestimate the toxicity of examined compounds.
For future applications of natural products and pure compounds it has been suggested SI > 2, and IC 50 values < 100 µg/mL and < 25 µM, as appropriate [22, 23] . In accordance with the data presented in Table 2 , the two tested EOs present promising antiviral activity that could make them suitable sources of active compounds against YFV, whereas citral and limonene do not. Citral seemed to contribute to the cytotoxicity and antiviral effects of L. citriodora taking into account that the CC 50 and IC 50 values of the two were in the same range. In contrast, limonene seemed to have an insignificant role in the anti-YFV activity of the examined EOs.
It has been suggested that the mixture of constituents in an EO has a greater potential than a single constituent towards antiviral activity [6, 18] . For YFV, a mixture containing citral and limonene could have potential usage, given that: i) citral-inhibited YFV, and the compound presented promising activity in vitro (SI of 12.9) against Herpes Simplex, another enveloped virus [18] ; ii) addition of d-limonene diminishes the cytotoxicity of citral [24] ; iii) no mutagenic, carcinogenic or nephrotoxic effect of limonene has been demonstrated [25] ; and iv) limonene has been clinically used to dissolve cholesterol-containing gallstones, and Flavivirus depends on cholesterol to replicate in the cell [26] .
The precise mechanism of the antiviral action of EOs and their isolated constituents is still not fully understood. In this study citral and Lippia EOs were active before and after virus adsorption. It seems that the compounds could inactivate YFV masking proteins on the envelope that are necessary for entry into the host cell, and the compounds could interfere with specific intracellular events of the YFV cycle. Studies have demonstrated the inactivation of enveloped viruses due to pre-treatment with either an EO or its constituents [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . On the contrary, we did not observe inhibition after adsorption on dengue virus due to treatment with Lippia EOs under similar experimental conditions [27] , and the same has been reported with respect to other enveloped viruses [7] [8] [9] [10] . The extraction and chemical compositions of the EOs were as described [27] . To use in experiments, the EO was dissolved in dimethyl sulfoxide (1%) and diluted in the culture medium. The main EO constituents are shown in Table 3 .
Experimental

Essential oils (Eos):
Synthetic compounds:
(R)-(+)-Limonene (97% purity) and citral (neral and geranial; 95% purity) were purchased from Sigma Aldrich Co. (USA). Dextran-sulfate (DS: MW 500,000) and ribavirin (both from Sigma) were included as control drugs. Limonene and citral were dissolved in a solution of 1% DMSO in test medium and ribavirin and DS in test medium.
Cytotoxicity assay: Viability of HeLa and Vero cells was measured by using the MTT assay, following a previously described protocol [27] . Briefly, cells grown in 96-well plates for 24 h were incubated in M-199 medium containing the appropriate concentration of test compound for 3 days at 37 o C. Next, medium was removed and MTT solution (5 mg/mL) was added to each well. The extent of MTT reduction to formazan was quantified by measuring the optical density (OD) at 595 nm. Data are expressed as CC 50 or concentration of compound that reduces the OD 595 of treated cells to 50% with respect to untreated cells. The maximum nontoxic concentration (MNTC) was also determined.
In vitro antiviral effect
Before adsorption: A previously described protocol was followed [15] . Briefly, YFV (50 PFU) was incubated with medium containing an appropriate concentration of compound for 2 h at 37ºC and the mixture was added to Vero cells grown in a 24-well plate. After 1 h of incubation at 37°C in a humidified 5%-CO 2 atmosphere, the plate was washed twice and then incubated in medium containing 5% FCS and 3% carboxymethyl-cellulose.
Each compound was analyzed in duplicate in 2 independent experiments. Virus-infected cells in medium containing DS or medium free of test compound were included on each plate as controls. After 6 days, cells were fixed with formaldehyde, then stained with 1% crystal violet, and virus plaques counted. The concentration of test compound that reduced plaque number by 50% (IC 50 ) with respect to control was calculated (by regression analysis of the dose-response curves generated from the data).
After adsorption: A previously described protocol was followed [15] . Untreated-YFV at MOI of 1 was adsorbed onto Vero cells grown in 24-well plates for 1 h at 37°C, and then cells were washed and incubated in M-199 medium containing concentrations of compound. At 48 h after incubation, the culture medium was collected to determine virus titer by plaque assay. Each compound was analyzed in duplicate in 2 independent experiments, and virusinfected cells in medium containing ribavirin or medium free of compound were included as controls. The concentration of compound that reduced virus titer (PFU/mL) by 50% (IC 50 ) with respect to untreated control was calculated.
Treatment of cells:
A previously described protocol was followed [15] . Confluent monolayers of Vero cells grown in a 24-well plate were exposed to concentrations of compound for 24 h at 37°C and then washed 3 times to remove residual compound. Untreated-YFV at MOI of 1 was allowed to adsorb onto treated-cells for 1 h at 37°C; after that, unabsorbed virus was removed by cell washes and the plate was incubated in M-199 medium with 5% FCS at 37°C. Each compound was analyzed in duplicate in 2 independent experiments, and virus-infected cell in medium without compound was included as control. After 2 days of incubation, the culture medium was collected to determine the virus titer by plaque assay.
Data analysis:
The selectivity index (SI) was calculated as the ratio of CC 50 to IC 50 . Data are shown as mean ± SD and Student's test was used to establish significant differences between compounds. [27] 
